MarketBeat Instant News Alerts 2 hours agoThe Goldman Sachs Group Begins Coverage on Amylyx Pharmaceuticals (NASDAQ:AMLX)MarketBeatThe Goldman Sachs Group initiated coverage on shares of Amylyx Pharmaceuticals in a research report on Thursday. They set a "buy" rating and a $10.00 target price for the company.NASDAQ:AMLXRead The Goldman Sachs Group Begins Coverage on Amylyx Pharmaceuticals (NASDAQ:AMLX)2 hours agoArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated by Analysts at The Goldman Sachs GroupMarketBeatThe Goldman Sachs Group started coverage on ArriVent BioPharma in a research report on Thursday. They set a "buy" rating and a $33.00 price target on the stock.NASDAQ:AVBPRead ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated by Analysts at The Goldman Sachs Group2 hours agoThe Goldman Sachs Group Initiates Coverage on CG Oncology (NASDAQ:CGON)MarketBeatThe Goldman Sachs Group began coverage on shares of CG Oncology in a research report on Thursday. They issued a "buy" rating and a $40.00 target price for the company.NASDAQ:CGONRead The Goldman Sachs Group Initiates Coverage on CG Oncology (NASDAQ:CGON)2 hours agoHalozyme Therapeutics (NASDAQ:HALO) Now Covered by The Goldman Sachs GroupMarketBeatThe Goldman Sachs Group began coverage on shares of Halozyme Therapeutics in a research note on Thursday. They issued a "neutral" rating and a $55.00 price objective for the company.NASDAQ:HALORead Halozyme Therapeutics (NASDAQ:HALO) Now Covered by The Goldman Sachs Group2 hours agoThe Goldman Sachs Group Initiates Coverage on Harmony Biosciences (NASDAQ:HRMY)MarketBeatThe Goldman Sachs Group assumed coverage on shares of Harmony Biosciences in a report on Thursday. They set a "neutral" rating and a $33.00 target price on the stock.NASDAQ:HRMYRead The Goldman Sachs Group Initiates Coverage on Harmony Biosciences (NASDAQ:HRMY)2 hours agoIDEAYA Biosciences (NASDAQ:IDYA) Earns Neutral Rating from Analysts at The Goldman Sachs GroupMarketBeatThe Goldman Sachs Group assumed coverage on shares of IDEAYA Biosciences in a research report on Thursday. They issued a "neutral" rating and a $25.00 price target for the company.NASDAQ:IDYARead IDEAYA Biosciences (NASDAQ:IDYA) Earns Neutral Rating from Analysts at The Goldman Sachs Group Trending News1QuantumScape (NYSE:QS) Stock Rating Upgraded by TD Cowen2Wolfspeed (NYSE:WOLF) Trading Up 83% - Time to Buy?3D-Wave Quantum Inc. (NYSE:QBTS) Shares Acquired by Vontobel Holding Ltd.4Cannabis Stocks To Follow Now - July 7th5Applied Digital (NASDAQ:APLD) Stock Price Down 7.6% - Should You Sell?6New York State Teachers Retirement System Boosts Stock Holdings in GameStop Corp. (NYSE:GME)7Best Cannabis Stocks To Keep An Eye On - July 8th8Wolfspeed (NYSE:WOLF) Shares Purchased by Vontobel Holding Ltd. All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoImmunovant (NASDAQ:IMVT) Coverage Initiated by Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:IMVTRead Immunovant (NASDAQ:IMVT) Coverage Initiated by Analysts at The Goldman Sachs Group2 hours agoAvidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:RNARead Avidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at The Goldman Sachs Group2 hours agoRoivant Sciences (NASDAQ:ROIV) Earns Buy Rating from Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:ROIVRead Roivant Sciences (NASDAQ:ROIV) Earns Buy Rating from Analysts at The Goldman Sachs Group2 hours agoTG Therapeutics (NASDAQ:TGTX) Earns Neutral Rating from Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:TGTXRead TG Therapeutics (NASDAQ:TGTX) Earns Neutral Rating from Analysts at The Goldman Sachs Group2 hours agoLake Street Capital Begins Coverage on Transcat (NASDAQ:TRNS)MarketBeatNASDAQ:TRNSRead Lake Street Capital Begins Coverage on Transcat (NASDAQ:TRNS)2 hours agoEstee Lauder Companies (NYSE:EL) Now Covered by Bank of AmericaMarketBeatNYSE:ELRead Estee Lauder Companies (NYSE:EL) Now Covered by Bank of America2 hours agoAlan B Lancz & Associates Inc. Acquires New Position in Eversource Energy (NYSE:ES)MarketBeatNYSE:ESRead Alan B Lancz & Associates Inc. Acquires New Position in Eversource Energy (NYSE:ES)2 hours ago7,378 Shares in Schlumberger Limited (NYSE:SLB) Bought by Alan B Lancz & Associates Inc.MarketBeatNYSE:SLBRead 7,378 Shares in Schlumberger Limited (NYSE:SLB) Bought by Alan B Lancz & Associates Inc.2 hours agoRackla Metals (CVE:RAK) Stock Price Up 7.8% - Here's WhyMarketBeatCVE:RAKRead Rackla Metals (CVE:RAK) Stock Price Up 7.8% - Here's Why2 hours agoLithium Americas (TSE:LAC) Trading 6.4% Higher - What's Next?MarketBeatTSE:LACRead Lithium Americas (TSE:LAC) Trading 6.4% Higher - What's Next?2 hours agoPOET Technologies (CVE:PTK) Shares Up 15.1% - Should You Buy?MarketBeatCVE:PTKRead POET Technologies (CVE:PTK) Shares Up 15.1% - Should You Buy?2 hours agoEnergy Fuels (TSE:EFR) Trading 16.3% Higher - Here's What HappenedMarketBeatTSE:EFRRead Energy Fuels (TSE:EFR) Trading 16.3% Higher - Here's What Happened2 hours agoAlan B Lancz & Associates Inc. Acquires 3,000 Shares of Shopify Inc. (NYSE:SHOP)MarketBeatNYSE:SHOPRead Alan B Lancz & Associates Inc. Acquires 3,000 Shares of Shopify Inc. (NYSE:SHOP)2 hours agoMcdonald Capital Investors Inc. CA Sells 13,469 Shares of NIKE, Inc. (NYSE:NKE)MarketBeatNYSE:NKERead Mcdonald Capital Investors Inc. CA Sells 13,469 Shares of NIKE, Inc. (NYSE:NKE)2 hours agoMcdonald Capital Investors Inc. CA Sells 33,721 Shares of Wells Fargo & Company (NYSE:WFC)MarketBeatNYSE:WFCRead Mcdonald Capital Investors Inc. CA Sells 33,721 Shares of Wells Fargo & Company (NYSE:WFC)2 hours agoMcdonald Capital Investors Inc. CA Cuts Position in Netflix, Inc. (NASDAQ:NFLX)MarketBeatNASDAQ:NFLXRead Mcdonald Capital Investors Inc. CA Cuts Position in Netflix, Inc. (NASDAQ:NFLX)2 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Mcdonald Capital Investors Inc. CAMarketBeatNASDAQ:REGNRead Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Mcdonald Capital Investors Inc. CA2 hours agoPaychex, Inc. (NASDAQ:PAYX) Shares Sold by Mcdonald Capital Investors Inc. CAMarketBeatNASDAQ:PAYXRead Paychex, Inc. (NASDAQ:PAYX) Shares Sold by Mcdonald Capital Investors Inc. CA2 hours agoBrookfield Asset Management Ltd. (NYSE:BAM) Shares Sold by Mcdonald Capital Investors Inc. CAMarketBeatNYSE:BAMRead Brookfield Asset Management Ltd. (NYSE:BAM) Shares Sold by Mcdonald Capital Investors Inc. CA2 hours agoUnion Pacific Corporation (NYSE:UNP) Shares Sold by Mcdonald Capital Investors Inc. CAMarketBeatNYSE:UNPRead Union Pacific Corporation (NYSE:UNP) Shares Sold by Mcdonald Capital Investors Inc. CA2 hours agoMcdonald Capital Investors Inc. CA Trims Position in Elevance Health, Inc. (NYSE:ELV)MarketBeatNYSE:ELVRead Mcdonald Capital Investors Inc. CA Trims Position in Elevance Health, Inc. (NYSE:ELV)2 hours agoArcus Capital Partners LLC Makes New Investment in Mr. Cooper Group Inc (NASDAQ:COOP)MarketBeatNASDAQ:COOPRead Arcus Capital Partners LLC Makes New Investment in Mr. Cooper Group Inc (NASDAQ:COOP)2 hours agoArcus Capital Partners LLC Takes $762,000 Position in PTC Inc. (NASDAQ:PTC)MarketBeatNASDAQ:PTCRead Arcus Capital Partners LLC Takes $762,000 Position in PTC Inc. (NASDAQ:PTC)2 hours agoArcus Capital Partners LLC Lowers Stake in Goldman Sachs BDC, Inc. (NYSE:GSBD)MarketBeatNYSE:GSBDRead Arcus Capital Partners LLC Lowers Stake in Goldman Sachs BDC, Inc. (NYSE:GSBD) Featured Articles and Offers3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendAI Meltdown Imminent: Dump These Stocks Now!From Paradigm Press(Ad)View AI Meltdown Imminent: Dump These Stocks Now!How a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerTraders Purchase High Volume of Call Options on Tilray Brands (NASDAQ:TLRY)By MarketBeat | July 6, 2025View Traders Purchase High Volume of Call Options on Tilray Brands (NASDAQ:TLRY)D-Wave Is Rising Again Despite Dilution—What’s the Deal?By Nathan Reiff | July 7, 2025View D-Wave Is Rising Again Despite Dilution—What’s the Deal?Crypto Is Pumping Again – Now Comes the Real OpportunityFrom Crypto Swap Profits(Ad)View Crypto Is Pumping Again – Now Comes the Real OpportunityQuantumScape (NYSE:QS) Stock Rating Upgraded by TD CowenBy MarketBeat | July 9, 2025View QuantumScape (NYSE:QS) Stock Rating Upgraded by TD CowenWolfspeed (NYSE:WOLF) Trading Up 83% - Time to Buy?By MarketBeat | July 9, 2025View Wolfspeed (NYSE:WOLF) Trading Up 83% - Time to Buy? Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
